194 related articles for article (PubMed ID: 32890776)
1. DUSP4 appears to be a highly localized endogenous inhibitor of epileptic signaling in human neocortex.
Kirchner A; Bagla S; Dachet F; Loeb JA
Neurobiol Dis; 2020 Nov; 145():105073. PubMed ID: 32890776
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition.
Cagnol S; Rivard N
Oncogene; 2013 Jan; 32(5):564-76. PubMed ID: 22430215
[TBL] [Abstract][Full Text] [Related]
3. Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.
Balko JM; Schwarz LJ; Bhola NE; Kurupi R; Owens P; Miller TW; Gómez H; Cook RS; Arteaga CL
Cancer Res; 2013 Oct; 73(20):6346-58. PubMed ID: 23966295
[TBL] [Abstract][Full Text] [Related]
4. Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.
Mazumdar A; Poage GM; Shepherd J; Tsimelzon A; Hartman ZC; Den Hollander P; Hill J; Zhang Y; Chang J; Hilsenbeck SG; Fuqua S; Kent Osborne C; Mills GB; Brown PH
Breast Cancer Res Treat; 2016 Aug; 158(3):441-54. PubMed ID: 27393618
[TBL] [Abstract][Full Text] [Related]
5. Statins affect ETS1-overexpressing triple-negative breast cancer cells by restoring DUSP4 deficiency.
Jung HH; Lee SH; Kim JY; Ahn JS; Park YH; Im YH
Sci Rep; 2016 Sep; 6():33035. PubMed ID: 27604655
[TBL] [Abstract][Full Text] [Related]
6. ARID1A loss activates MAPK signaling via DUSP4 downregulation.
Mandal J; Yu ZC; Shih IM; Wang TL
J Biomed Sci; 2023 Dec; 30(1):94. PubMed ID: 38071325
[TBL] [Abstract][Full Text] [Related]
7. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.
Gröschl B; Bettstetter M; Giedl C; Woenckhaus M; Edmonston T; Hofstädter F; Dietmaier W
Int J Cancer; 2013 Apr; 132(7):1537-46. PubMed ID: 22965873
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.
Ichimanda M; Hijiya N; Tsukamoto Y; Uchida T; Nakada C; Akagi T; Etoh T; Iha H; Inomata M; Takekawa M; Moriyama M
Cancer Sci; 2018 Jan; 109(1):250-258. PubMed ID: 29150975
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-α-mediated suppression of dual-specificity phosphatase 4: crosstalk between NFκB and MAPK regulates endothelial cell survival.
Kao DD; Oldebeken SR; Rai A; Lubos E; Leopold JA; Loscalzo J; Handy DE
Mol Cell Biochem; 2013 Oct; 382(1-2):153-62. PubMed ID: 23812841
[TBL] [Abstract][Full Text] [Related]
10. Impaired Dual-Specificity Protein Phosphatase DUSP4 Reduces Corticosteroid Sensitivity.
Kobayashi Y; Ito K; Kanda A; Tomoda K; Mercado N; Barnes PJ
Mol Pharmacol; 2017 May; 91(5):475-481. PubMed ID: 28283554
[TBL] [Abstract][Full Text] [Related]
11. Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation.
Choi JC; Wu W; Muchir A; Iwata S; Homma S; Worman HJ
J Biol Chem; 2012 Nov; 287(48):40513-24. PubMed ID: 23048029
[TBL] [Abstract][Full Text] [Related]
12. Methylation of dual-specificity phosphatase 4 controls cell differentiation.
Su H; Jiang M; Senevirathne C; Aluri S; Zhang T; Guo H; Xavier-Ferrucio J; Jin S; Tran NT; Liu SM; Sun CW; Zhu Y; Zhao Q; Chen Y; Cable L; Shen Y; Liu J; Qu CK; Han X; Klug CA; Bhatia R; Chen Y; Nimer SD; Zheng YG; Iancu-Rubin C; Jin J; Deng H; Krause DS; Xiang J; Verma A; Luo M; Zhao X
Cell Rep; 2021 Jul; 36(4):109421. PubMed ID: 34320342
[TBL] [Abstract][Full Text] [Related]
13. DUSP4 Inactivation Leads to Reduced Extracellular Signal‒Regulated Kinase Activity through Upregulation of DUSP6 in Melanoma Cells.
Kamada H; Yasuhira S; Shibazaki M; Amano H; Maesawa C
J Invest Dermatol; 2022 Sep; 142(9):2499-2507.e6. PubMed ID: 35189148
[TBL] [Abstract][Full Text] [Related]
14. Activity-dependent gene expression correlates with interictal spiking in human neocortical epilepsy.
Rakhade SN; Shah AK; Agarwal R; Yao B; Asano E; Loeb JA
Epilepsia; 2007; 48 Suppl 5():86-95. PubMed ID: 17910586
[TBL] [Abstract][Full Text] [Related]
15. Redox activation of DUSP4 by N-acetylcysteine protects endothelial cells from Cd²⁺-induced apoptosis.
Barajas-Espinosa A; Basye A; Jesse E; Yan H; Quan D; Chen CA
Free Radic Biol Med; 2014 Sep; 74():188-199. PubMed ID: 24973647
[TBL] [Abstract][Full Text] [Related]
16. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5.
Echavarria R; Hussain SN
J Am Heart Assoc; 2013 Dec; 2(6):e000571. PubMed ID: 24308939
[TBL] [Abstract][Full Text] [Related]
17. Investigating the Role of DUSP4 in Uveal Melanoma.
Aughton K; Sabat-Pospiech D; Barlow S; Coupland SE; Kalirai H
Transl Vis Sci Technol; 2022 Dec; 11(12):13. PubMed ID: 36576731
[TBL] [Abstract][Full Text] [Related]
18. DUSP4 is involved in the enhanced proliferation and survival of DUSP4-overexpressing cancer cells.
Ratsada P; Hijiya N; Hidano S; Tsukamoto Y; Nakada C; Uchida T; Kobayashi T; Moriyama M
Biochem Biophys Res Commun; 2020 Jul; 528(3):586-593. PubMed ID: 32505357
[TBL] [Abstract][Full Text] [Related]
19. DUSP4 inhibits autophagic cell death in PTC by inhibiting JNK-BCL2-Beclin1 signaling.
He H; Du Z; Lin J; Wu W; Yu Y
Biochem Cell Biol; 2021 Oct; 99(5):554-561. PubMed ID: 33621155
[TBL] [Abstract][Full Text] [Related]
20. Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance.
Balko JM; Cook RS; Vaught DB; Kuba MG; Miller TW; Bhola NE; Sanders ME; Granja-Ingram NM; Smith JJ; Meszoely IM; Salter J; Dowsett M; Stemke-Hale K; González-Angulo AM; Mills GB; Pinto JA; Gómez HL; Arteaga CL
Nat Med; 2012 Jul; 18(7):1052-9. PubMed ID: 22683778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
